Diagnostics

RSS

PIVKA-II test kit for HCC launched in Japan

Dec. 18, 2013

Novel radioligand described for imaging Abeta in AD

Dec. 18, 2013

Navidea Biopharmaceuticals submits supplemental NDA to FDA for Lymphoseek

Dec. 18, 2013

Endocyte begins phase I study of EC-1456 in advanced solid tumors

Dec. 16, 2013

C4 Imaging receives FDA 510(k) clearance for Sirius

Dec. 13, 2013

KU Leuven and Biocartis to develop diagnostic test for MMR-deficient cancer

Dec. 13, 2013

FDA grants fast track designation to Navidea Biopharmaceuticals' Lymphoseek

Dec. 11, 2013

Noninvasive diagnostic agent for early detection of pulmonary hypertension reported

Dec. 10, 2013

Navidea Biopharmaceuticals begins phase III registration program for NAV-5001

Dec. 4, 2013

Navidea to collaborate with UAB on study of RIGS monoclonal antibody targeting agent

Dec. 2, 2013